Skip to main content
SpringerLink
Log in

The Drugs Controller General (India), FDA Bhawan New Delhi, has mandated that a boxed warning be added to the labels of nimesulide formulations

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Indian Pharmacopoeia Commission.Regulatory matters - Nimesulide. Pharmacovigilance Programme of India (PvPI) Newsletter 2: 4, 15 Aug 2012

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Drugs Controller General (India), FDA Bhawan New Delhi, has mandated that a boxed warning be added to the labels of nimesulide formulations. React. Wkly. 1418, 2 (2012). https://doi.org/10.2165/00128415-201214180-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00005

Keywords

Search

Navigation